-

AV Laboratories Appoints Dr. Dendy Engelman to Scientific Advisory Board

NEW YORK--(BUSINESS WIRE)--AV Laboratories, a biotechnology-driven skincare brand focused on clinical longevity, today announced the appointment of Dr. Dendy Engelman, MD, FACMS, FAAD, to its Scientific Advisory Board.

A board-certified dermatologist and Mohs surgeon, Dr. Engelman is nationally recognized for her evidence-based, “less-is-more” approach to skin health and aesthetics. Based in New York City, she brings extensive experience across medical, cosmetic, and surgical dermatology, as well as deep involvement in clinical research, physician education, and product development within the skincare and pharmaceutical industries.

In her role on the AV Laboratories Scientific Advisory Board, Dr. Engelman will provide expert guidance on clinical strategy, product development, and scientific positioning as the brand continues to advance its mission to deliver longevity-focused skincare powered by breakthrough biotechnology.

“Dr. Engelman represents the intersection of clinical excellence and future-forward dermatology,” said Sylwia Pawlaczyk, COO. “Her expertise and perspective will be invaluable as we continue to elevate the standard for science-backed skincare and invest in technologies that support skin wellness at the molecular level.”

Dr. Engelman added, “I’m excited to join the Scientific Advisory Board at AV Laboratories at a time when the conversation around longevity and skin health is rapidly evolving. AVL’s commitment to rigorous science and meaningful innovation aligns deeply with my own philosophy of patient-first, evidence-based care. I look forward to contributing to the brand’s continued research and development efforts.”

AV Laboratories’ Scientific Advisory Board is composed of leading physicians and researchers who support the brand’s commitment to clinically-backed, biotechnology-driven skincare solutions.

For more information, visit www.avlaboratories.com.

About AV Laboratories

AV Laboratories is a science-driven skincare company dedicated to advancing clinical longevity through biotechnology-powered formulations. Built on rigorous research and physician collaboration, the brand is committed to delivering clinically validated solutions that support skin wellness now and for decades to come.

Contacts

Media Contact:
Marlee Martinez | Valleymade PR
marlee@valleymade.co

AV Laboratories


Release Summary
AV Laboratories appoints dermatologist Dr. Dendy Engelman to its Scientific Advisory Board to guide longevity-focused skincare innovation.
Release Versions

Contacts

Media Contact:
Marlee Martinez | Valleymade PR
marlee@valleymade.co

Social Media Profiles
More News From AV Laboratories

AV Laboratories, Founded by Pioneers of IVF Solutions, to Launch Fertility Clinic Program Featuring Its Award-Winning Skincare at ESHRE 2026 in London

LONDON--(BUSINESS WIRE)--AV Laboratories, a science-led skincare company founded by pioneers in IVF solutions, regenerative medicine, and stem cell therapy, today announced it will exhibit at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE 2026, taking place in London from 5 - 8 July 2026. The company will welcome clinicians, embryologists, fertility specialists, researchers, partners, and industry participants at Booth A22. “ESHRE is deeply personal...

AVL Hosts Virtual Salon Suite Exploring How IVF Research Inspired a New Era of Science-Backed Skincare

NEW YORK--(BUSINESS WIRE)--AV Laboratories, the science-backed skincare brand redefining the intersection of science, skincare, and longevity, will host an exclusive virtual salon suite on Thursday, May 21, 2026 at 11:00 AM EST for editors, media, and industry insiders. The 30-minute informational session will explore the next frontier of skincare innovation, highlighting the scientific discoveries and advanced research philosophies that inspired AVL’s development and are reshaping the industry...

From IVF Science to Skin Longevity: AV Laboratories Translates Biotechnology into Breakthrough Skincare

NEW YORK--(BUSINESS WIRE)--AV Laboratories is redefining the future of skincare by translating decades of advanced biotechnology research into clinically driven formulations designed for everyday use. Rooted in expertise spanning IVF and stem cell science, the company is pioneering a new category of molecular skincare focused on supporting skin longevity at the cellular level. At the center of AV Laboratories’ innovation is its patented AVL SOM3® complex, a scientifically engineered formulation...
Back to Newsroom